Fair Value Measurements and Hierarchy (Tables)

12 Months Ended

Dec. 31, 2021

Class of Warrant or Right [Line Items]

Schedule of carrying amounts of financial instruments

	Successor		Predecessor
	December 31,		December 31,
	2021		2020
Financial Assets:
Cash	$	140,477,586	$	36,261,104
Restricted Cash	$	356,286	$	3,641,843
Clinics Fees and Insurance Receivables, Net	$	1,090,104	$	675,954
Other Receivables	$	726,903	$	146,117
Financial Liabilities:
Accounts Payable and Accrued Expenses	$	17,730,683	$	11,793,125
Liability for Warrants	$	11,382,826	$	6,316,605

Summary of changes in company's Level 3 fair value measurements

	Successor		Predecessor
	December 3, 2021
	through				Year
	December 31,		January 1, 2021		Ended
	2021		through		December
	(Private		December 2, 2021		31, 2020
	Placement		(Class D		(Class D
	Warrants)		Warrants)		Warrants)
Beginning Balance	$	793,650	$	6,316,605	$	N/A
Issuance of Class D Warrants		—		—		6,316,605
Mark-to-Market Adjustment for Stock Warrants		(291,374)		7,664,869		—
Ending Balance	$	502,276	$	13,981,474	$	6,316,605

Class D Warrants

Class of Warrant or Right [Line Items]

Summary of Level 3 inputs into option pricing model

Volatility		65.0	%
Risk-Free Interest rate		0.10	%
Exercise Price	$	4.68
Expected Term		1.1	Years

Private Placement Warrants

Class of Warrant or Right [Line Items]

Summary of Level 3 inputs into option pricing model

Volatility		60.0	%
Risk-Free Interest rate		1.26	%
Exercise Price	$	11.50
Expected Term		4.9	Years